Model
Edge
Ascendis Pharma
0001965612
Filing Type
4
Filing Date
5/11/2026
Updated
5/12/26, 2:08 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership